Clinical Trial Update: Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicating completion of Phase 1/Phase 2 testing of a topical 3% amphotericin B cream for Cutaneous Leishmaniasis in Colombia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Topical Amphotericin B 3% Cream (amphotericin B)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Cutaneous Leishmaniasis | Phase 1, Phase 2 | Status: COMPLETED